Register information Patent

DE file number : 60 2016 070 971.6 (Status: pending/in force, Query started: April 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INID	Criterion	Field	Content
	Type of IP right	SART	Patent
	Status	ST	Pending/in force
21	DE file number	DAKZ	60 2016 070 971.6
96	EP file number	EAKZ	19 16 7051.2
97	EP publication number	EPN	3527574
54	Designation/title	TI	ALVOCIDIB-PRODRUGS MIT ERHÖHTER BIOVERFÜGBARKEIT
51	IPC main class	ICM (ICMV)	C07F 9/12 (2006.01)
51	IPC secondary class(es)	ICS (ICSV)	A61K 31/661 (2006.01), A61P 35/00 (2006.01)
22	DE application date	DAT	May 18, 2016
96	EP application date	EAT	May 18, 2016
43	Date of first publication	OT	Aug 21, 2019
	Date of publication of grant	PET	Apr 6, 2022
71/73	Applicant/owner	INH	Sumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Marlborough, MA, US
72	Inventor	IN	SIDDIQUI-JAIN, Adam, South Jordan, Utah 84095, US; BEARSS, David J., Alpine, Utah 84004, US
74	Representative	VTR	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE
	Address for service		HOFFMANN-EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE
33 31 32	Foreign priority	PRC PRNA PRDA	US 201562163188 P May 18, 2015
	Due date	FT FG	May 31, 2026 Annual fee for the 11th year Patent fees
	Patent division in charge		44
97	EP language of publication	ELANG	EN - Englisch
84	Designated EP contracting states	EDS	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
	Published EP/WO documents	EPWOPN	Original document: EP000003527574A1 Searchable text: EP000003527574A1 Original document: EP000003527574B1 Searchable text: EP000003527574B1
43	Date of first publication	EVT	Aug 21, 2019
	Date of the first transfer into DPMAregister	EREGT	Aug 21, 2019
	Date of the (most recent) update in DPMAregister	REGT	Apr 2, 2025 (Show all update days)(Hide all update days) Apr 2, 2025 Due date: changed Nov 12, 2024 Representative: changed Oct 10, 2024 St.36: changed (technical change) Jun 8, 2024; May 16, 2024; Aug 24, 2023; Jul 19, 2023; Jun 7, 2023; Mar 30, 2023; Feb 23, 2023; Jul 1, 2022; Jun 14, 2022; Jun 8, 2022; Apr 21, 2022; Mar 19, 2022; Mar 17, 2022 Historical data not available for this/these date(s) Aug 21, 2019 Date of the first transfer into DPMAregister

Procedural data
No.	Kind of procedure	Legal status	Date of legal/procedural status	Publication date	Alle Details anzeigen
1	Procedure relating to EP application	EPO 1st publication	Aug 21, 2019		Details anzeigen
2	Publications	Publication of a mention regarding EP 1st publication by DPMA	Oct 2, 2019	Oct 2, 2019	Details anzeigen
3	Procedure relating to EP application	EPO publication of mention regarding patent grant (beginning of opposition period)	Apr 6, 2022		Details anzeigen
4	Publications	Publication by DPMA of mention regarding EP patent grant	Apr 28, 2022	Apr 28, 2022	Details anzeigen
5	New applicant/owner details	New applicant/owner details	Jun 13, 2022	Jul 21, 2022	Details anzeigen
6	Procedure relating to EP application	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision	Jan 10, 2023	Mar 30, 2023	Details anzeigen
7	New applicant/owner details	New applicant/owner details	Jul 18, 2023	Aug 24, 2023	Details anzeigen

View procedures Procedure relating to EP application (No.: 1)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO 1st publication
Date of legal/procedural status	VSTT	Aug 21, 2019

View procedures Publications (No.: 2)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural status	VSTT	Oct 2, 2019
Issue number	HN	40
Year	PJ	2019
Publication date	VT	Oct 2, 2019
Type of publication	PART	Bibliographic data

View procedures Procedure relating to EP application (No.: 3)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural status	VSTT	Apr 6, 2022
Date of update of the procedure	REGT	Mar 17, 2022

View procedures Publications (No.: 4)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication by DPMA of mention regarding EP patent grant
Date of legal/procedural status	VSTT	Apr 28, 2022
Issue number	HN	17
Year	PJ	2022
Publication date	VT	Apr 28, 2022
Type of publication	PART	Bibliographic data
Part	HT	Part 5
Date of update of the procedure	REGT	Apr 21, 2022

View procedures New applicant/owner details (No.: 5)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Jun 13, 2022
	Issue number	HN	29
	Year	PJ	2022
	Publication date	VT	Jul 21, 2022
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Sumitomo Pharma Oncology, Inc., Cambridge, MA, US
71/73	Previous applicant/owner	INHF	Sumitomo Dainippon Pharma Oncology, Inc., Cambridge, MA, US
	Date of update of the procedure	REGT	Jul 1, 2022

View procedures Procedure relating to EP application (No.: 6)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural status	VSTT	Jan 10, 2023
Issue number	HN	13
Year	PJ	2023
Publication date	VT	Mar 30, 2023
Type of publication	PART	Bibliographic data
Part	HT	Part 3
Date of update of the procedure	REGT	Mar 30, 2023

View procedures New applicant/owner details (No.: 7)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Jul 18, 2023
	Issue number	HN	34
	Year	PJ	2023
	Publication date	VT	Aug 24, 2023
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Sumitomo Pharma Oncology, Inc. (n. d. Ges. d. Staates Delaware), Marlborough, MA, US
71/73	Previous applicant/owner	INHF	Sumitomo Pharma Oncology, Inc., Cambridge, MA, US
	Date of update of the procedure	REGT	Aug 24, 2023